Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas

OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kovatchev, Boris P., Renard, Eric, Cobelli, Claudio, Zisser, Howard C., Keith-Hynes, Patrick, Anderson, Stacey M., Brown, Sue A., Chernavvsky, Daniel R., Breton, Marc D., Mize, Lloyd B., Farret, Anne, Place, Jérôme, Bruttomesso, Daniela, Del Favero, Simone, Boscari, Federico, Galasso, Silvia, Avogaro, Angelo, Magni, Lalo, Di Palma, Federico, Toffanin, Chiara, Messori, Mirko, Dassau, Eyal, Doyle, Francis J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2014
Aiheet:
Diabetes Care Symposium
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067397/
https://ncbi.nlm.nih.gov/pubmed/24929429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-2076
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia